Rafael Araos
Overview
Explore the profile of Rafael Araos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quesille-Villalobos A, Solar C, Martinez J, Rivas L, Quiroz V, Gonzalez A, et al.
Antimicrob Agents Chemother
. 2024 Dec;
69(1):e0120524.
PMID: 39636127
Carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) represent a significant global threat. The emergence of dual CP-CRE is particularly alarming, as they can potentially compromise the efficacy of newer antibiotics, further decreasing therapeutic...
2.
Gutierrez B, Tsui J, Pullano G, Mazzoli M, Gangavarapu K, Inward R, et al.
PNAS Nexus
. 2024 Nov;
3(11):pgae483.
PMID: 39525554
Human mobility is strongly associated with the spread of SARS-CoV-2 via air travel on an international scale and with population mixing and the number of people moving between locations on...
3.
Royo-Cebrecos C, Laporte-Amargos J, Pena M, Ruiz-Camps I, Garcia-Vidal C, Abdala E, et al.
Microorganisms
. 2024 Apr;
12(4).
PMID: 38674650
This large, multicenter, retrospective cohort study including onco-hematological neutropenic patients with bloodstream infection (PABSI) found that among 1213 episodes, 411 (33%) presented with septic shock. The presence of solid tumors...
4.
Jara A, Cuadrado C, Undurraga E, Garcia C, Najera M, Bertoglia M, et al.
Nat Commun
. 2023 Oct;
14(1):6836.
PMID: 37884492
In light of the ongoing COVID-19 pandemic and the emergence of new SARS-CoV-2 variants, understanding the effectiveness of various booster vaccination regimens is pivotal. In Chile, using a prospective national...
5.
Allel K, Peters A, Conejeros J, Martinez J, Spencer-Sandino M, Riquelme-Neira R, et al.
Clin Infect Dis
. 2023 Jul;
77(Suppl 1):S20-S28.
PMID: 37406053
Background: The impact of coronavirus disease 2019 (COVID-19) on antimicrobial use (AU) and resistance has not been well evaluated in South America. These data are critical to inform national policies...
6.
Araos R, Smith R, Styczynski A, Sanchez F, Acevedo J, Maureira L, et al.
Clin Infect Dis
. 2023 Jul;
77(Suppl 1):S75-S81.
PMID: 37406045
Background: Antimicrobial resistance is a global threat, heavily impacting low- and middle-income countries. This study estimated antimicrobial-resistant gram-negative bacteria (GNB) fecal colonization prevalence in hospitalized and community-dwelling adults in Chile...
7.
Martinez J, Planet P, Spencer-Sandino M, Rivas L, Diaz L, Moustafa A, et al.
Microbiol Spectr
. 2023 Jun;
11(4):e0535122.
PMID: 37338398
The global dissemination of methicillin-resistant Staphylococcus aureus (MRSA) is associated with the emergence and establishment of clones in specific geographic areas. The Chilean-Cordobes clone (ChC) (ST5-SCCI) has been the predominant...
8.
Martinez J, Alcalde-Rico M, Jara-Videla E, Rios R, Moustafa A, Hanson B, et al.
bioRxiv
. 2023 Jun;
PMID: 37293062
Methicillin-resistant Staphylococcus aureus (MRSA) is a priority pathogen listed by the World Health Organization. The global spread of MRSA is characterized by successive waves of epidemic clones that predominate in...
9.
Jara A, Undurraga E, Flores J, Zubizarreta J, Gonzalez C, Pizarro A, et al.
Lancet Reg Health Am
. 2023 May;
21:100487.
PMID: 37155483
Background: Policymakers urgently need evidence to adequately balance the costs and benefits of mass vaccination against COVID-19 across all age groups, including children and adolescents. In this study, we aim...
10.
Ruiz-Tagle C, Ugalde J, Naves R, Araos R, Garcia P, Balcells M
Sci Rep
. 2023 May;
13(1):7301.
PMID: 37147354
The upper respiratory tract is an obliged pathway for respiratory pathogens and a healthy microbiota may support the host's mucosal immunity preventing infection. We analyzed the nasopharyngeal microbiome in tuberculosis...